This federal contract award from the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, provides $9,741.00 to the University of North Carolina at Chapel Hill (UNC-CH) for custom adeno-associated virus (AAV) preparation to be used in experiments for the Spinal Circuits and Plasticity Laboratory. The contract is a firm fixed-price purchase order with a period of performance through April 2026. The contract has no set-aside designation, indicating UNC-CH competed...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $563,541.00 base award contract by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract, titled "Screening Vaccine (and Other Biologics) Platform Technologies Using Coronavirus Mouse Immunogenicity as a Model System," is part of the larger NIAID Preclinical Models of Infectious Diseases 2017-2024 contract vehicle. The contract has a ceiling value of $2,254,164.00 and...
This is a $9,122.52 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) on August 12, 2015. The contract has an ultimate completion date of August 31, 2015 and was not set aside for any specific business category. UNC-Chapel Hill is a U.S. state government entity and institution of higher learning that...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $14,727,929.36 definitive contract to the University of North Carolina at Chapel Hill (UNC) to conduct biomedical (applied/exploratory) research. The contract, which does not have a set-aside designation, runs from February 2, 2009 to July 31, 2018. As a public research university, UNC's Office of Sponsored Research provides a wide range of goods and services to the federal...
This federal contract award to the University of North Carolina at Chapel Hill (UNC-CH), Office of Sponsored Research, is for $142,000 in research services. The contract is a firm fixed price purchase order, with a completion date of August 31, 2016. It was awarded on July 31, 2015 by the Centers for Disease Control and Prevention (CDC), which is part of the U.S. Department of Health and Human Services. UNC-CH is a major public research university that receives substantial federal funding for...
This is a $271,640.00 firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill to perform Task A36 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The award has an 18 month period of performance and does not utilize any set-aside designations. The University of North Carolina at Chapel...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $146,246 firm fixed price purchase order to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) to provide immunological data on 9 vaccines. The award does not have a set-aside designation. UNC-Chapel Hill, through its Kenan Flagler Business School, has provided various training and research services to federal agencies, including the Centers for...
The National Heart Lung and Blood Institute (NHLBI), a Civilian agency, awarded a $154,439,309.43 Definitive Contract to the University of North Carolina at Chapel Hill (UNC-CH) on August 28, 1985 with a completion date of June 22, 2015. The contract is for biomedical research and services, and is not set-aside. UNC-CH, which operates under the name Office of Sponsored Research, is a major public research university with extensive experience managing large federal R&D projects across a range...
The U.S. National Heart Lung and Blood Institute, a civilian agency, awarded a $34,328,258.21 definitive cost-type contract to the University of North Carolina at Chapel Hill to provide research and services. The contract, which does not have a set-aside designation, has an ultimate completion date of March 29, 2013. The University of North Carolina at Chapel Hill, a U.S. state government entity and institution of higher learning, will perform the work through its Carolina Institute for...
This is a $26,209,615.84 cost-no-fee definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the Department of Health and Human Services (HHS), to the University of North Carolina at Chapel Hill (UNC-CH) for biomedical research. The contract has an ultimate completion date of June 30, 2017 and was originally awarded on September 30, 2006. The contract does not have a set-aside designation. UNC-CH has extensive experience managing large-scale federal...